- Home
- ANEB vs TPST Comparison
ANEB vs TPST Comparison
Compare ANEB & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- TPST
- Stock Information
- Founded
- ANEB 2020
- TPST 2011
- Country
- ANEB United States
- TPST United States
- Employees
- ANEB N/A
- TPST N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- ANEB Health Care
- TPST Health Care
- Exchange
- ANEB Nasdaq
- TPST Nasdaq
- Market Cap
- ANEB 36.7M
- TPST 40.4M
- IPO Year
- ANEB 2021
- TPST N/A
- Fundamental
- Price
- ANEB $1.43
- TPST $0.83
- Analyst Decision
- ANEB Buy
- TPST Strong Buy
- Analyst Count
- ANEB 1
- TPST 3
- Target Price
- ANEB $8.00
- TPST $21.67
- AVG Volume (30 Days)
- ANEB 25.7K
- TPST 618.1K
- Earning Date
- ANEB 02-14-2025
- TPST 05-08-2025
- Dividend Yield
- ANEB N/A
- TPST N/A
- EPS Growth
- ANEB N/A
- TPST N/A
- EPS
- ANEB N/A
- TPST N/A
- Revenue
- ANEB N/A
- TPST N/A
- Revenue This Year
- ANEB N/A
- TPST N/A
- Revenue Next Year
- ANEB N/A
- TPST N/A
- P/E Ratio
- ANEB N/A
- TPST N/A
- Revenue Growth
- ANEB N/A
- TPST N/A
- 52 Week Low
- ANEB $0.80
- TPST $0.70
- 52 Week High
- ANEB $3.30
- TPST $6.00
- Technical
- Relative Strength Index (RSI)
- ANEB 58.07
- TPST 47.67
- Support Level
- ANEB $0.91
- TPST $0.77
- Resistance Level
- ANEB $1.70
- TPST $0.85
- Average True Range (ATR)
- ANEB 0.19
- TPST 0.05
- MACD
- ANEB 0.04
- TPST 0.00
- Stochastic Oscillator
- ANEB 65.91
- TPST 62.16
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.